CellVoyant

CellVoyant provides an AI-driven platform for cell-based therapeutic development, utilizing label-free imaging and predictive analysis to monitor and forecast cell states. Its FateView software predicts outcomes and critical quality attributes from cell images, while the FateDrive service simulates process variations to optimize manufacturing conditions. The technology targets biotechnology companies and researchers looking to reduce failed experiments and improve yield in stem cell-based therapy pipelines.